Skip to main content

Home/ Business News/ Group items matching "Gilead" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
1More

Healthcare Sector Sees Big Rise, Major Fall | equities.com - 0 views

editorial.equities.com/...ector-sees-big-rise-major-fall equities.com healthcare sector Synovis Life Technologies SYNO Baxter International BAX ECYT Endocyte clinical trials surgeries repair Pharmasset VRUS Gilead Sciences GILD biopharmaceutical IPO
shared by Equities Group on 13 Dec 11 - No Cached
  • Equities Group on 13 Dec 11
     
    One of the day's biggest gainers and biggest losers both came from the healthcare sector on news of a planned buyout and negative results from a clinical trial.
1More

5 High-Priced Stocks That Still Appeal to Investors - 0 views

editorial.equities.com/...5-stocks-high-price-appealing "Equities.com" "investing" "blue chips" "consumer discretionary" "energy" "financials" "healthcare" "technology" "materials" "stocks" "AAPL" "Apple" "valuations" "operating margins" "earnings" "Exxon" "XOM" "market cap" "Gilead Sciences" "GILD" "hepatitis
shared by Equities Group on 01 Feb 12 - No Cached
  • Equities Group on 01 Feb 12
     
    Stocks near their 52-week high are rarely an appealing buy for many value investors, but here are five names that could have the potential to keep growing anyway.
1More

Five Midcap Biotech Stocks Projecting Growth - 0 views

editorial.equities.com/...otech-stocks-projecting-growth "Equities.com" "biotech stocks" "growth" "healthcare "fundamental analysis" industry" "clinical trials" "Pharmasset" "VRUS" "Hepatitis C treatment" "Gilead Science" "GILD" "Amylin Pharmaceuticals" "AMLN" "diabetes" "obesity" "Eli Lilly" "LLY" "joint ventu
shared by Equities Group on 05 Mar 12 - No Cached
  • Equities Group on 05 Mar 12
     
    While biotech is not an industry for investors who are faint of heart, the potential for big returns can still make it attractive.
1More

Morning Call: Europe, US Debt Woes Send Market to Lower Open | equities.com - 0 views

editorial.equities.com/...woes-send-market-to-lower-open equities.com U.S. Debt Europe EQ1 stocks technical analysis trading wall street Scott Redler FED France AAA Spain Mariano Rajoy Wang Qishan VRUS Pharmasset Gilead Scinces GILD Transatlantic Holdings TRH ETF SCO
shared by Equities Group on 21 Nov 11 - No Cached
  • Equities Group on 21 Nov 11
     
    Deep differences among Super Committee members on opinion over tax and spending reforms made it impossible to strike a compromise, marking another market-negative catalyst.
1More

Companies with Something to be Thankful For | equities.com - 0 views

editorial.equities.com/...stocks-to-be-thankful-for "Equities.com" "technology" "financials" "Joel Anderson" "healthcare" "Seagate Technology" "STX" "technology manufacturers" "Western Digital Corporation" "WDC" "Pharmasset" "VRUS" "GILD" "Gilead Sciences" "American Capital Agency Corp." "AGNC" "real estat
shared by Equities Group on 25 Nov 11 - No Cached
  • Equities Group on 25 Nov 11
     
    In honor of the Thanksgiving holiday, we're offering up some folks with something to be thankful for in 2011, whether it be big returns or a lucky break.
1More

General Anesthesia Drugs Market Value May Be Headed Higher In 2022: The Reports and Ins... - 0 views

reportsandinsights.com/...eneral-anesthesia-drugs-market Anesthesia Drugs Market Research Report Share 2021 Size 2022 Trends Key Players Global Analysis Industry News Forecast CAGR USA
shared by bheru_kumar on 04 Oct 22 - No Cached
  • bheru_kumar on 04 Oct 22
     
    The report is titled as 'General Anesthesia Drugs Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the General Anesthesia Drugs market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
1More

Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Merger, Acquisition, SWOT Analys... - 0 views

reportsandinsights.com/...patitis-nash-biomarkers-market Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report Share 2021 Size 2022 Trends Key Players Global Analysis Industry News Forecast CAGR USA Japan Demand Argentina Australia Belgium Brazil Canada
shared by bheru_kumar on 24 Aug 22 - No Cached
  • bheru_kumar on 24 Aug 22
     
    The report is titled as 'Non-alcoholic Steatohepatitis (NASH) Biomarkers Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Non-alcoholic Steatohepatitis (NASH) Biomarkers market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
1More

Small Molecule API Market Segmentation, Regional Analysis, Size, Share and Forecast by ... - 0 views

reportsandinsights.com/...small-molecule-api-market Small Molecule API Market Research Report Share 2021 Size 2022 Trends Key Players Global Analysis Industry News Forecast CAGR USA
shared by bheru_kumar on 25 Aug 22 - No Cached
  • bheru_kumar on 25 Aug 22
     
    The report is titled as 'Small Molecule API Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Small Molecule API market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
1 - 8 of 8
Showing 20▼ items per page